Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
The CRISPR Journal
|
December 18, 2023
Modified Cas9-Guided Oxford Nanopore Technology Sequencing Uncovers Single and Multiple Transgene Insertion Sites in a Zebrafish Melanoma Model
Raffaella De Paolo, Uday Munagala, Francesco Cucco, et al.
Disease Markers
|
September 6, 2016
GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications
Filippo Martignano, Giorgia Gurioli, Samanta Salvi, et al.
Disease Markers
|
September 29, 2015
Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients
Samanta Salvi, Giorgia Gurioli, Filippo Martignano, et al.
Molecular Cancer
|
February 13, 2021
Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
Filippo Martignano, Uday Munagala, Stefania Crucitta, et al.
Journal of Translational Medicine
|
September 1, 2016
Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach
Giorgia Gurioli, Samanta Salvi, Filippo Martignano, et al.
Genome Biology
|
July 15, 2022
Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing
Efrat Katsman, Shari Orlanski, Filippo Martignano, et al.
Oncotarget
|
February 11, 2017
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer
Roberta Maltoni, Valentina Casadio, Sara Ravaioli, et al.
International Journal of Molecular Sciences
|
December 6, 2017
Immunotherapy for Prostate Cancer: Where We Are Headed
Giuseppe Schepisi, Alberto Farolfi, Vincenza Conteduca, et al.
Anti-Cancer Drugs
|
January 19, 2022
Growth arrest-specific 5 lncRNA as a valuable biomarker of chemoresistance in osteosarcoma
Simone Polvani, Filippo Martignano, Guido Scoccianti, et al.
Oncotarget
|
May 19, 2016
Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer
Samanta Salvi, Valentina Casadio, Vincenza Conteduca, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
The CRISPR Journal
|
December 18, 2023
Modified Cas9-Guided Oxford Nanopore Technology Sequencing Uncovers Single and Multiple Transgene Insertion Sites in a Zebrafish Melanoma Model
Raffaella De Paolo, Uday Munagala, Francesco Cucco, et al.
Disease Markers
|
September 6, 2016
GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications
Filippo Martignano, Giorgia Gurioli, Samanta Salvi, et al.
Disease Markers
|
September 29, 2015
Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients
Samanta Salvi, Giorgia Gurioli, Filippo Martignano, et al.
Molecular Cancer
|
February 13, 2021
Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
Filippo Martignano, Uday Munagala, Stefania Crucitta, et al.
Journal of Translational Medicine
|
September 1, 2016
Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach
Giorgia Gurioli, Samanta Salvi, Filippo Martignano, et al.
Genome Biology
|
July 15, 2022
Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing
Efrat Katsman, Shari Orlanski, Filippo Martignano, et al.
Oncotarget
|
February 11, 2017
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer
Roberta Maltoni, Valentina Casadio, Sara Ravaioli, et al.
International Journal of Molecular Sciences
|
December 6, 2017
Immunotherapy for Prostate Cancer: Where We Are Headed
Giuseppe Schepisi, Alberto Farolfi, Vincenza Conteduca, et al.
Anti-Cancer Drugs
|
January 19, 2022
Growth arrest-specific 5 lncRNA as a valuable biomarker of chemoresistance in osteosarcoma
Simone Polvani, Filippo Martignano, Guido Scoccianti, et al.
Oncotarget
|
May 19, 2016
Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer
Samanta Salvi, Valentina Casadio, Vincenza Conteduca, et al.
Page
of 2